RTI Biologics (RTIX) Misses Street's Q4 Views; Guides FY10 EPS Inline
Tweet Send to a Friend
RTI Biologics, Inc. (NASDAQ: RTIX) reports Q4 EPS of $0.03 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
